Global Immunoprecipitation Market to value over USD 720 million and register a CAGR of over 4% during the forecast period, 2019 to 2026.
Immunoprecipitation finds wide applications in the medical industry. They are also heavily employed in the research of various applications such as targeted protein purification, protein concentration, analysis of protein-protein interactions, identification or analysis of protein complexes, and analysis of protein or DNA. WIth rising activities in the research sector and advancements in the life sciences industry, the global immunoprecipitation market is forecasted to bolster during the projected time frame. There is an upsurge and rising need for quick and accurate diagnosis and identification of antigens associated with autoimmune diseases through antigen-antibody interaction which thus creates opportunities on a global scale for the expansion of immunoprecipitation market size. This is vital in understanding disease mechanisms and developing effective and relevant drugs targeting these diseases. Therefore, with rising consciousness, the need for these services is rising and is expected to accelerate the CAGR of the market during the forecast period.
Based on type, the immunoprecipitation market is segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation and RNA immunoprecipitation. The individual immunoprecipitation segment is predicted to attain the largest immunoprecipitation market share and grow at the fastest CAGR during the projected time frame.
The increasing use of immunoprecipitation in the research of protein-protein interactions, antigen diagnosis, and to determine the relative quantity of an antigen are the driving factors for segment growth in various research studies during the forecast period.
By product type, the market is segmented into kits, reagents and accessories. The segment of kits is projected to grow at the fastest CAGR in the immunoprecipitation market during the forecast period. Growth in this market can be attributed to factors such as the requirement for the repurchase of kits coupled with the increasing number of IP assays to isolate and purify antigens.
Based on the region, North America holds a major market share in the immunoprecipitation market and is predicted to continue the same pattern during the forecast period. The substantial market share of this region can be attributed to rising integrated research in the field of genomics and proteomics, presence of numerous academic and research institutes, and the market characterised by established global players in this region. Asia Pacific will grow at a healthy CAGR due to rising awareness, boost in research activities and growth in the bio-chemicals industry.
Prominent market players include Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, GenScript, and BioLegend, Cell Signaling Technology, Rockland Immunochemicals, Takara Bio, and Geno Technology.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3381&page=requestsample
Global Immunoprecipitation Market Segmentation
By Type
● Individual Immunoprecipitation
● Co-Immunoprecipitation
● Chromatin Immunoprecipitation
● RNA Immunoprecipitation

By Product
● Kits
● Reagents
■ Antibodies
➢ By Type
○ Primary Antibodies
○ Secondary Antibodies
■ Beads
➢ By Type
○ Agarose Beads
○ Magnetic Beads
○ Buffers
● Accessories

By End User
● Academic & Research Institutes
● Pharmaceutical & Biotechnology Companies
● Contract Research Organizations

By Region
● North America
● Europe
● Asia Pacific
● Latin America
● Middle East & Africa
Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3381&page=askfordiscount
Competitive Landscape
● Thermo Fisher Scientific opened its new bioprocess design centre in Shanghai to connect and collaborate with biologic developers to design optimal bioprocessing solutions
● Abcam entered into an agreement with Roche, a leading biotech company, under which Abcam obtained the exclusive rights to the product portfolio of Spring, which consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products

Objectives of the Study:
● To provide with an exhaustive analysis on the global immunoprecipitation market by type, by product, by end-user, and by region
● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and the overall market
● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Break Down of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Assumptions for the Study
3 Executive Summary

4 Premium Insights
4.1 Immunoprecipitation: Market Overview
4.2 Immunoprecipitation Market, By Product (2018–2026)
4.3 North America: Immunoprecipitation Market, By Type (2018)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Number of Life Sciences Research Activities
5.2.1.2 Growing Need to Identify Antigens That are Associated With Autoimmune Diseases
5.2.2 Restraints
5.2.2.1 Presence of Alternative Technologies
5.2.3 Opportunities
5.2.3.1 Increasing Focus on Biomarker Discovery
5.2.4 Challenges
5.2.4.1 Quality Concerns Over Research Antibodies

6 Immunoprecipitation Market, By Type
6.1 Introduction
6.2 Individual Immunoprecipitation
6.2.1 Increasing Demand for Biologics is Driving the Growth of the Market
6.3 Co-Immunoprecipitation
6.3.1 Increasing Use of Co-Ip to Study Protein Complexes Forms A Key Market Driver
6.4 Chromatin Immunoprecipitation
6.4.1 Growing Adoption of High-Throughput Technologies Will Contribute to Adoption of Chip
6.5 Rna Immunoprecipitation
6.5.1 Availability of Government Funding Will Drive the Adoption of Rip Kits

7 Immunoprecipitation Market, By Product
7.1 Introduction
7.2 Kits
7.2.1 Kits Segment to Account for the Largest Share of the Immunoprecipitation Market During the Forecast Period
7.3 Reagents
7.3.1 Antibodies
7.3.1.1 Antibodies, By Type
7.3.1.1.1 Primary Antibodies
7.3.1.1.1.1 Primary Antibodies to Account for the Largest Share of the Immunoprecipitation Antibodies Market During the Forecast Period
7.3.1.1.2 Secondary Antibodies
7.3.1.1.2.1 Low Cost of Production - A Major Factor Driving the Growth of the Secondary Antibodies Market
7.3.2 Beads
7.3.2.1 Beads, By Type
7.3.2.2 Agarose Beads
7.3.2.2.1 High Binding Capacity and Lower Cost – Factors Supporting the Wide Use of Agarose Beads in Research Laboratories
7.3.2.3 Magnetic Beads
7.3.2.3.1 Magnetic Bead-Based Separation Helps Increase Throughput and Reduces Hands-On Time
7.3.2.4 Buffers
7.3.2.4.1 Buffer Solutions Play an Important Role in Maintaining Ph Balance in Ip Assays
7.4 Accessories

8 Immunoprecipitation Market, By End User
8.1 Introduction
8.2 Academic & Research Institutes
8.2.1 Academic & Research Institutes are the Largest End Users of Immunoprecipitation
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Increasing Demand for Protein-Based Drugs to Drive the Demand for Immunoprecipitation in This End-User Segment
8.4 Contract Research Organizations
8.4.1 Growth in Outsourcing of Protein Purification Activities - A Major Factor Driving the Demand for Immunoprecipitation Technologies in Contract Research Organizations

9 Immunoprecipitation Market, By Region
9.1 Introduction
9.2 North America
9.2.1 Us
9.2.1.1 Growing Research Will Drive Market Growth
9.2.2 Canada
9.2.2.1 Increasing Genomics and Proteomics Research to Drive the Adoption of Immunoprecipitation in the Coming Years
9.3 Europe
9.3.1 Growth of the Life Sciences Sector Will Support the Demand for Immunoprecipitation
9.4 Asia Pacific
9.4.1 Increasing Demand for Novel Antibody and Protein-Based Drugs Support Market Growth in the Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Vendor Benchmarking
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Market Ranking Analysis, 2018
10.5 Competitive Situation and Trends
10.5.1 Expansions
10.5.2 Collaborations, Partnerships, and Agreements
10.5.3 Product Launches
10.5.4 Acquisitions

11 Company Profiles
(Business Overview, Products Offered, Recent Developments, FutureWise Perspective)*
11.1 Thermo Fisher Scientific
11.2 Abcam
11.3 Genscript
11.4 Merck KGaA
11.5 Bio-Rad Laboratories
11.6 Biolegend
11.7 Takara Bio
11.8 Rockland Immunochemicals
11.9 Cell Signaling Technology
11.10 Geno Technology

12. Assumptions and Acronyms
13. Research Methodology
14. List of Sources of Information (Primary and Secondary)
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com